MDCO Stock Ownership Activity

MEDICINES COMPANY 13F holders

No value investing guru has made any change to the MEDICINES COMPANY (MDCO) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying MDCO now?

According to the latest SEC filing(s) MEDICINES COMPANY (MDCO) has not been purchased by any super investor.

To see more about who is investing in MEDICINES COMPANY (MDCO), please go to the MDCO ownership page.

2020 Q1 (1 result)
David Einhorn
-100.00%
-229,900
-2.80%
0.00%
Reported price*: $84.94
2019 Q4 (1 result)
David Einhorn
-68.58%
-501,700
-3.16%
0.00%
Reported price*: $84.94
2019 Q2 (2 results)
David Einhorn
-22.89%
-128,148
-0.58%
1.16%
Quincy Lee
-100.00%
-27,520
-0.12%
0.00%
AVG reported price*: $36.47
2019 Q1 (1 result)
Quincy Lee
buy
+27,520
+0.14%
0.00%
Reported price*: $27.94
2018 Q3 (1 result)
David Einhorn
-5.12%
-46,336
-0.06%
1.08%
Reported price*: $29.91
2017 Q4 (1 result)
David Einhorn
buy
+1,000,000
+0.50%
0.50%
Reported price*: $27.34
7 of 7

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.